Political Leaders Need to invest in Global Research & Development to Prepare for Next Pandemic 30/08/2022 CEPI & UNITE Recently, the Coalition for Epidemic Preparedness (CEPI) launched a $3.5 billion plan of investment in ground-breaking R&D, linked to equitable access commitments, which aims to transform the world’s ability to respond to new epidemic and pandemic threats and catalyze cooperation across a coalition of public and private sector partners. As parliamentarians from across the European […] Continue reading -> WHO Urges Universal Monkeypox Fight 30/08/2022 John Heilprin The World Health Organization’s top official in Europe says the monkeypox outbreak appears to be slowing in the region, and could be eliminated through universal effort. “There are encouraging early signs, as evidenced in France, Germany, Portugal, Spain, the U.K., and other countries, that the outbreak may be slowing,” WHO’s Regional Director for Europe Dr […] Continue reading -> Swiss Approve 1st Booster for Variants 29/08/2022 John Heilprin Swiss drugs regulator Swissmedic announced it has temporarily authorized the first bivalent Covid-19 booster vaccine in the country. That clears the way for an eagerly anticipated second round of booster vaccinations that should better target Omicron sub-variants. Moderna’s COVID-19 mRNA-1273.214 vaccine, Spikevax, is the first COVID-19 vaccine that contains messenger ribonucleic acid (mRNA) against two […] Continue reading -> WHO Lists Entities That Can Engage with Pandemic Treaty Negotiating Body 29/08/2022 Kerry Cullinan A wide range of groups including civil society, academic and health groups have been identified as stakeholders that are able to interact with the World Health Organization’s (WHO) Intergovernmental Negotiating Body (INB) on a pandemic preparedness instrument. The WHO published the list last week but stressed that it was a “living document with further possibilities […] Continue reading -> How to Know if You Should Work in Global Health 27/08/2022 Editorial team For emerging global health professionals from the world’s “south,” choosing whether to focus their energy on local issues or on international challenges is always a dilemma, Chief Planetary Health Scientist of Sunway Centre for Planetary Health in Malaysia Renzo Guinto argues. “One important crossroad that I’ve encountered is tension on whether I stay in the […] Continue reading -> Poor Vaccines Coverage in Pandemic Blamed on Multiple Barriers 26/08/2022 John Heilprin & Dann Okoth Some of the biggest obstacles to expanded vaccines coverage in the world’s poorest and most conflict-ridden nations are lack of cold chain storage, unpredictable supply chains, and transport barriers, not claims of “vaccine hesitancy” in the Global South, according to a new report. The picture of the steep challenges faced by 14 nations during the […] Continue reading -> Africa Has Not Received a Single Dose of Monkeypox Vaccine – Even Though Virus is Endemic and Often More Deadly 25/08/2022 Paul Adepoju Another COVID rerun: WHO and Africa CDC officials lament the complete lack of access to monkeypox vaccines on the continent where the virus is endemic – as well as often more deadly than elsewhere. Meanwhile, Mozambique and Malawi have seen a total of six wild poliovirus cases, although WHO officials continue to insist that since […] Continue reading -> Monkeypox Cases Drop 21% Globally As WHO Weighs ‘Fractional’ Vaccine Dose Strategy 25/08/2022 John Heilprin The global number of weekly new cases of monkeypox reported to the World Health Organization (WHO) declined by 21% for the first time since the infection that has been endemic to central and west Africa began to appear around the world earlier this year. Cases continued rising sharply in the Americas, however, in contrast to […] Continue reading -> Chronic Disease Focus of New Strategy 25/08/2022 Paul Adepoju Ministers and government officials took on noncommunicable diseases, sickle cell disease, health system reforms in response to the COVID-19 pandemic, and measures to fight tuberculosis among children in Africa during their meeting of the 72nd WHO Regional Committee for Africa this week. In an effort to curb Africa’s chronic disease crisis, African health ministers adopted […] Continue reading -> NEJM Study: Pfizer’s Paxlovid Reduces COVID-19 Death by 81% in Older Adults, Not Effective in Younger Patients 24/08/2022 Maayan Hoffman Pfizer’s COVID-19 oral antiviral Paxlovid was found to reduce the mortality rate among people over the age of 65 by 81% in a new Israeli study published Wednesday in the New England Journal of Medicine. However, the study also found no significant benefit of the drug in patients aged 64 and younger. It is the […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Urges Universal Monkeypox Fight 30/08/2022 John Heilprin The World Health Organization’s top official in Europe says the monkeypox outbreak appears to be slowing in the region, and could be eliminated through universal effort. “There are encouraging early signs, as evidenced in France, Germany, Portugal, Spain, the U.K., and other countries, that the outbreak may be slowing,” WHO’s Regional Director for Europe Dr […] Continue reading -> Swiss Approve 1st Booster for Variants 29/08/2022 John Heilprin Swiss drugs regulator Swissmedic announced it has temporarily authorized the first bivalent Covid-19 booster vaccine in the country. That clears the way for an eagerly anticipated second round of booster vaccinations that should better target Omicron sub-variants. Moderna’s COVID-19 mRNA-1273.214 vaccine, Spikevax, is the first COVID-19 vaccine that contains messenger ribonucleic acid (mRNA) against two […] Continue reading -> WHO Lists Entities That Can Engage with Pandemic Treaty Negotiating Body 29/08/2022 Kerry Cullinan A wide range of groups including civil society, academic and health groups have been identified as stakeholders that are able to interact with the World Health Organization’s (WHO) Intergovernmental Negotiating Body (INB) on a pandemic preparedness instrument. The WHO published the list last week but stressed that it was a “living document with further possibilities […] Continue reading -> How to Know if You Should Work in Global Health 27/08/2022 Editorial team For emerging global health professionals from the world’s “south,” choosing whether to focus their energy on local issues or on international challenges is always a dilemma, Chief Planetary Health Scientist of Sunway Centre for Planetary Health in Malaysia Renzo Guinto argues. “One important crossroad that I’ve encountered is tension on whether I stay in the […] Continue reading -> Poor Vaccines Coverage in Pandemic Blamed on Multiple Barriers 26/08/2022 John Heilprin & Dann Okoth Some of the biggest obstacles to expanded vaccines coverage in the world’s poorest and most conflict-ridden nations are lack of cold chain storage, unpredictable supply chains, and transport barriers, not claims of “vaccine hesitancy” in the Global South, according to a new report. The picture of the steep challenges faced by 14 nations during the […] Continue reading -> Africa Has Not Received a Single Dose of Monkeypox Vaccine – Even Though Virus is Endemic and Often More Deadly 25/08/2022 Paul Adepoju Another COVID rerun: WHO and Africa CDC officials lament the complete lack of access to monkeypox vaccines on the continent where the virus is endemic – as well as often more deadly than elsewhere. Meanwhile, Mozambique and Malawi have seen a total of six wild poliovirus cases, although WHO officials continue to insist that since […] Continue reading -> Monkeypox Cases Drop 21% Globally As WHO Weighs ‘Fractional’ Vaccine Dose Strategy 25/08/2022 John Heilprin The global number of weekly new cases of monkeypox reported to the World Health Organization (WHO) declined by 21% for the first time since the infection that has been endemic to central and west Africa began to appear around the world earlier this year. Cases continued rising sharply in the Americas, however, in contrast to […] Continue reading -> Chronic Disease Focus of New Strategy 25/08/2022 Paul Adepoju Ministers and government officials took on noncommunicable diseases, sickle cell disease, health system reforms in response to the COVID-19 pandemic, and measures to fight tuberculosis among children in Africa during their meeting of the 72nd WHO Regional Committee for Africa this week. In an effort to curb Africa’s chronic disease crisis, African health ministers adopted […] Continue reading -> NEJM Study: Pfizer’s Paxlovid Reduces COVID-19 Death by 81% in Older Adults, Not Effective in Younger Patients 24/08/2022 Maayan Hoffman Pfizer’s COVID-19 oral antiviral Paxlovid was found to reduce the mortality rate among people over the age of 65 by 81% in a new Israeli study published Wednesday in the New England Journal of Medicine. However, the study also found no significant benefit of the drug in patients aged 64 and younger. It is the […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Swiss Approve 1st Booster for Variants 29/08/2022 John Heilprin Swiss drugs regulator Swissmedic announced it has temporarily authorized the first bivalent Covid-19 booster vaccine in the country. That clears the way for an eagerly anticipated second round of booster vaccinations that should better target Omicron sub-variants. Moderna’s COVID-19 mRNA-1273.214 vaccine, Spikevax, is the first COVID-19 vaccine that contains messenger ribonucleic acid (mRNA) against two […] Continue reading -> WHO Lists Entities That Can Engage with Pandemic Treaty Negotiating Body 29/08/2022 Kerry Cullinan A wide range of groups including civil society, academic and health groups have been identified as stakeholders that are able to interact with the World Health Organization’s (WHO) Intergovernmental Negotiating Body (INB) on a pandemic preparedness instrument. The WHO published the list last week but stressed that it was a “living document with further possibilities […] Continue reading -> How to Know if You Should Work in Global Health 27/08/2022 Editorial team For emerging global health professionals from the world’s “south,” choosing whether to focus their energy on local issues or on international challenges is always a dilemma, Chief Planetary Health Scientist of Sunway Centre for Planetary Health in Malaysia Renzo Guinto argues. “One important crossroad that I’ve encountered is tension on whether I stay in the […] Continue reading -> Poor Vaccines Coverage in Pandemic Blamed on Multiple Barriers 26/08/2022 John Heilprin & Dann Okoth Some of the biggest obstacles to expanded vaccines coverage in the world’s poorest and most conflict-ridden nations are lack of cold chain storage, unpredictable supply chains, and transport barriers, not claims of “vaccine hesitancy” in the Global South, according to a new report. The picture of the steep challenges faced by 14 nations during the […] Continue reading -> Africa Has Not Received a Single Dose of Monkeypox Vaccine – Even Though Virus is Endemic and Often More Deadly 25/08/2022 Paul Adepoju Another COVID rerun: WHO and Africa CDC officials lament the complete lack of access to monkeypox vaccines on the continent where the virus is endemic – as well as often more deadly than elsewhere. Meanwhile, Mozambique and Malawi have seen a total of six wild poliovirus cases, although WHO officials continue to insist that since […] Continue reading -> Monkeypox Cases Drop 21% Globally As WHO Weighs ‘Fractional’ Vaccine Dose Strategy 25/08/2022 John Heilprin The global number of weekly new cases of monkeypox reported to the World Health Organization (WHO) declined by 21% for the first time since the infection that has been endemic to central and west Africa began to appear around the world earlier this year. Cases continued rising sharply in the Americas, however, in contrast to […] Continue reading -> Chronic Disease Focus of New Strategy 25/08/2022 Paul Adepoju Ministers and government officials took on noncommunicable diseases, sickle cell disease, health system reforms in response to the COVID-19 pandemic, and measures to fight tuberculosis among children in Africa during their meeting of the 72nd WHO Regional Committee for Africa this week. In an effort to curb Africa’s chronic disease crisis, African health ministers adopted […] Continue reading -> NEJM Study: Pfizer’s Paxlovid Reduces COVID-19 Death by 81% in Older Adults, Not Effective in Younger Patients 24/08/2022 Maayan Hoffman Pfizer’s COVID-19 oral antiviral Paxlovid was found to reduce the mortality rate among people over the age of 65 by 81% in a new Israeli study published Wednesday in the New England Journal of Medicine. However, the study also found no significant benefit of the drug in patients aged 64 and younger. It is the […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Lists Entities That Can Engage with Pandemic Treaty Negotiating Body 29/08/2022 Kerry Cullinan A wide range of groups including civil society, academic and health groups have been identified as stakeholders that are able to interact with the World Health Organization’s (WHO) Intergovernmental Negotiating Body (INB) on a pandemic preparedness instrument. The WHO published the list last week but stressed that it was a “living document with further possibilities […] Continue reading -> How to Know if You Should Work in Global Health 27/08/2022 Editorial team For emerging global health professionals from the world’s “south,” choosing whether to focus their energy on local issues or on international challenges is always a dilemma, Chief Planetary Health Scientist of Sunway Centre for Planetary Health in Malaysia Renzo Guinto argues. “One important crossroad that I’ve encountered is tension on whether I stay in the […] Continue reading -> Poor Vaccines Coverage in Pandemic Blamed on Multiple Barriers 26/08/2022 John Heilprin & Dann Okoth Some of the biggest obstacles to expanded vaccines coverage in the world’s poorest and most conflict-ridden nations are lack of cold chain storage, unpredictable supply chains, and transport barriers, not claims of “vaccine hesitancy” in the Global South, according to a new report. The picture of the steep challenges faced by 14 nations during the […] Continue reading -> Africa Has Not Received a Single Dose of Monkeypox Vaccine – Even Though Virus is Endemic and Often More Deadly 25/08/2022 Paul Adepoju Another COVID rerun: WHO and Africa CDC officials lament the complete lack of access to monkeypox vaccines on the continent where the virus is endemic – as well as often more deadly than elsewhere. Meanwhile, Mozambique and Malawi have seen a total of six wild poliovirus cases, although WHO officials continue to insist that since […] Continue reading -> Monkeypox Cases Drop 21% Globally As WHO Weighs ‘Fractional’ Vaccine Dose Strategy 25/08/2022 John Heilprin The global number of weekly new cases of monkeypox reported to the World Health Organization (WHO) declined by 21% for the first time since the infection that has been endemic to central and west Africa began to appear around the world earlier this year. Cases continued rising sharply in the Americas, however, in contrast to […] Continue reading -> Chronic Disease Focus of New Strategy 25/08/2022 Paul Adepoju Ministers and government officials took on noncommunicable diseases, sickle cell disease, health system reforms in response to the COVID-19 pandemic, and measures to fight tuberculosis among children in Africa during their meeting of the 72nd WHO Regional Committee for Africa this week. In an effort to curb Africa’s chronic disease crisis, African health ministers adopted […] Continue reading -> NEJM Study: Pfizer’s Paxlovid Reduces COVID-19 Death by 81% in Older Adults, Not Effective in Younger Patients 24/08/2022 Maayan Hoffman Pfizer’s COVID-19 oral antiviral Paxlovid was found to reduce the mortality rate among people over the age of 65 by 81% in a new Israeli study published Wednesday in the New England Journal of Medicine. However, the study also found no significant benefit of the drug in patients aged 64 and younger. It is the […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
How to Know if You Should Work in Global Health 27/08/2022 Editorial team For emerging global health professionals from the world’s “south,” choosing whether to focus their energy on local issues or on international challenges is always a dilemma, Chief Planetary Health Scientist of Sunway Centre for Planetary Health in Malaysia Renzo Guinto argues. “One important crossroad that I’ve encountered is tension on whether I stay in the […] Continue reading -> Poor Vaccines Coverage in Pandemic Blamed on Multiple Barriers 26/08/2022 John Heilprin & Dann Okoth Some of the biggest obstacles to expanded vaccines coverage in the world’s poorest and most conflict-ridden nations are lack of cold chain storage, unpredictable supply chains, and transport barriers, not claims of “vaccine hesitancy” in the Global South, according to a new report. The picture of the steep challenges faced by 14 nations during the […] Continue reading -> Africa Has Not Received a Single Dose of Monkeypox Vaccine – Even Though Virus is Endemic and Often More Deadly 25/08/2022 Paul Adepoju Another COVID rerun: WHO and Africa CDC officials lament the complete lack of access to monkeypox vaccines on the continent where the virus is endemic – as well as often more deadly than elsewhere. Meanwhile, Mozambique and Malawi have seen a total of six wild poliovirus cases, although WHO officials continue to insist that since […] Continue reading -> Monkeypox Cases Drop 21% Globally As WHO Weighs ‘Fractional’ Vaccine Dose Strategy 25/08/2022 John Heilprin The global number of weekly new cases of monkeypox reported to the World Health Organization (WHO) declined by 21% for the first time since the infection that has been endemic to central and west Africa began to appear around the world earlier this year. Cases continued rising sharply in the Americas, however, in contrast to […] Continue reading -> Chronic Disease Focus of New Strategy 25/08/2022 Paul Adepoju Ministers and government officials took on noncommunicable diseases, sickle cell disease, health system reforms in response to the COVID-19 pandemic, and measures to fight tuberculosis among children in Africa during their meeting of the 72nd WHO Regional Committee for Africa this week. In an effort to curb Africa’s chronic disease crisis, African health ministers adopted […] Continue reading -> NEJM Study: Pfizer’s Paxlovid Reduces COVID-19 Death by 81% in Older Adults, Not Effective in Younger Patients 24/08/2022 Maayan Hoffman Pfizer’s COVID-19 oral antiviral Paxlovid was found to reduce the mortality rate among people over the age of 65 by 81% in a new Israeli study published Wednesday in the New England Journal of Medicine. However, the study also found no significant benefit of the drug in patients aged 64 and younger. It is the […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Poor Vaccines Coverage in Pandemic Blamed on Multiple Barriers 26/08/2022 John Heilprin & Dann Okoth Some of the biggest obstacles to expanded vaccines coverage in the world’s poorest and most conflict-ridden nations are lack of cold chain storage, unpredictable supply chains, and transport barriers, not claims of “vaccine hesitancy” in the Global South, according to a new report. The picture of the steep challenges faced by 14 nations during the […] Continue reading -> Africa Has Not Received a Single Dose of Monkeypox Vaccine – Even Though Virus is Endemic and Often More Deadly 25/08/2022 Paul Adepoju Another COVID rerun: WHO and Africa CDC officials lament the complete lack of access to monkeypox vaccines on the continent where the virus is endemic – as well as often more deadly than elsewhere. Meanwhile, Mozambique and Malawi have seen a total of six wild poliovirus cases, although WHO officials continue to insist that since […] Continue reading -> Monkeypox Cases Drop 21% Globally As WHO Weighs ‘Fractional’ Vaccine Dose Strategy 25/08/2022 John Heilprin The global number of weekly new cases of monkeypox reported to the World Health Organization (WHO) declined by 21% for the first time since the infection that has been endemic to central and west Africa began to appear around the world earlier this year. Cases continued rising sharply in the Americas, however, in contrast to […] Continue reading -> Chronic Disease Focus of New Strategy 25/08/2022 Paul Adepoju Ministers and government officials took on noncommunicable diseases, sickle cell disease, health system reforms in response to the COVID-19 pandemic, and measures to fight tuberculosis among children in Africa during their meeting of the 72nd WHO Regional Committee for Africa this week. In an effort to curb Africa’s chronic disease crisis, African health ministers adopted […] Continue reading -> NEJM Study: Pfizer’s Paxlovid Reduces COVID-19 Death by 81% in Older Adults, Not Effective in Younger Patients 24/08/2022 Maayan Hoffman Pfizer’s COVID-19 oral antiviral Paxlovid was found to reduce the mortality rate among people over the age of 65 by 81% in a new Israeli study published Wednesday in the New England Journal of Medicine. However, the study also found no significant benefit of the drug in patients aged 64 and younger. It is the […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Africa Has Not Received a Single Dose of Monkeypox Vaccine – Even Though Virus is Endemic and Often More Deadly 25/08/2022 Paul Adepoju Another COVID rerun: WHO and Africa CDC officials lament the complete lack of access to monkeypox vaccines on the continent where the virus is endemic – as well as often more deadly than elsewhere. Meanwhile, Mozambique and Malawi have seen a total of six wild poliovirus cases, although WHO officials continue to insist that since […] Continue reading -> Monkeypox Cases Drop 21% Globally As WHO Weighs ‘Fractional’ Vaccine Dose Strategy 25/08/2022 John Heilprin The global number of weekly new cases of monkeypox reported to the World Health Organization (WHO) declined by 21% for the first time since the infection that has been endemic to central and west Africa began to appear around the world earlier this year. Cases continued rising sharply in the Americas, however, in contrast to […] Continue reading -> Chronic Disease Focus of New Strategy 25/08/2022 Paul Adepoju Ministers and government officials took on noncommunicable diseases, sickle cell disease, health system reforms in response to the COVID-19 pandemic, and measures to fight tuberculosis among children in Africa during their meeting of the 72nd WHO Regional Committee for Africa this week. In an effort to curb Africa’s chronic disease crisis, African health ministers adopted […] Continue reading -> NEJM Study: Pfizer’s Paxlovid Reduces COVID-19 Death by 81% in Older Adults, Not Effective in Younger Patients 24/08/2022 Maayan Hoffman Pfizer’s COVID-19 oral antiviral Paxlovid was found to reduce the mortality rate among people over the age of 65 by 81% in a new Israeli study published Wednesday in the New England Journal of Medicine. However, the study also found no significant benefit of the drug in patients aged 64 and younger. It is the […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Monkeypox Cases Drop 21% Globally As WHO Weighs ‘Fractional’ Vaccine Dose Strategy 25/08/2022 John Heilprin The global number of weekly new cases of monkeypox reported to the World Health Organization (WHO) declined by 21% for the first time since the infection that has been endemic to central and west Africa began to appear around the world earlier this year. Cases continued rising sharply in the Americas, however, in contrast to […] Continue reading -> Chronic Disease Focus of New Strategy 25/08/2022 Paul Adepoju Ministers and government officials took on noncommunicable diseases, sickle cell disease, health system reforms in response to the COVID-19 pandemic, and measures to fight tuberculosis among children in Africa during their meeting of the 72nd WHO Regional Committee for Africa this week. In an effort to curb Africa’s chronic disease crisis, African health ministers adopted […] Continue reading -> NEJM Study: Pfizer’s Paxlovid Reduces COVID-19 Death by 81% in Older Adults, Not Effective in Younger Patients 24/08/2022 Maayan Hoffman Pfizer’s COVID-19 oral antiviral Paxlovid was found to reduce the mortality rate among people over the age of 65 by 81% in a new Israeli study published Wednesday in the New England Journal of Medicine. However, the study also found no significant benefit of the drug in patients aged 64 and younger. It is the […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Chronic Disease Focus of New Strategy 25/08/2022 Paul Adepoju Ministers and government officials took on noncommunicable diseases, sickle cell disease, health system reforms in response to the COVID-19 pandemic, and measures to fight tuberculosis among children in Africa during their meeting of the 72nd WHO Regional Committee for Africa this week. In an effort to curb Africa’s chronic disease crisis, African health ministers adopted […] Continue reading -> NEJM Study: Pfizer’s Paxlovid Reduces COVID-19 Death by 81% in Older Adults, Not Effective in Younger Patients 24/08/2022 Maayan Hoffman Pfizer’s COVID-19 oral antiviral Paxlovid was found to reduce the mortality rate among people over the age of 65 by 81% in a new Israeli study published Wednesday in the New England Journal of Medicine. However, the study also found no significant benefit of the drug in patients aged 64 and younger. It is the […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
NEJM Study: Pfizer’s Paxlovid Reduces COVID-19 Death by 81% in Older Adults, Not Effective in Younger Patients 24/08/2022 Maayan Hoffman Pfizer’s COVID-19 oral antiviral Paxlovid was found to reduce the mortality rate among people over the age of 65 by 81% in a new Israeli study published Wednesday in the New England Journal of Medicine. However, the study also found no significant benefit of the drug in patients aged 64 and younger. It is the […] Continue reading -> Posts navigation Older postsNewer posts